
In comparison to the RECIST 1.1 criteria, use of the mpMRI-based NacBI-RADS system for evaluating response to neoadjuvant chemotherapy (NAC) for breast cancer offered an 8 percent higher sensitivity and over 26 percent higher specificity.
Siemens has inked an exclusive distribution deal with a DutchPACS developer to market that company's products in the Netherlands.Siemens will distribute the RadWorks line of software developedby Applicare Medical Imaging of Alphen aan den Rijn, the
Siemens has inked an exclusive distribution deal with a DutchPACS developer to market that company's products in the Netherlands.Siemens will distribute the RadWorks line of software developedby Applicare Medical Imaging of Alphen aan den Rijn, the Netherlands.RadWorks runs on the Windows NT operating system and supportsthe ACR-NEMA's DICOM 3.0 standard. RadWorks will complement Siemens'own line of PACS products, according to the companies.





